GRACE, LUNGevity announce free webinar program to highlight lung cancer research

NewsGuard 100/100 Score
Editorial Checklist Reviewed
Jun 20 2011LUNGevity Foundation

LUNGevity Foundation and GRACE announce a free webinar program to provide the highlights in lung cancer research from the American Society for Clinical Oncology (ASCO) Annual Meeting held June 3-6, 2011 in Chicago.  

ASCO, the largest cancer conference of the year, is where the majority of the landmark clinical research in cancer care are presented.  On the webinar participants will learn the results of the key research and also have it placed into context with valuable commentary by two expert lung cancer oncologists.

Source:

LUNGevity Foundation

Posted in: Medical Research News | Medical Condition News

Tags: , , , , , ,

Comments (0)

Suggested Reading

Plant-based diets could reduce the chances of disease progression in men with prostate cancer
Research validates anti-inflammatory properties of wine using urinary tartaric acid as biomarker
Blood proteins predict cancer risk seven years in advance, studies find
Can virtual reality be the future of brain health? New research suggests VR exercise enhances working memory
Study reveals latest cancer trends in Canada
What is the ‘immune self,’ and how can this concept benefit immunological research?
Proteins in the blood could warn people of cancer more than seven years before it is diagnosed
Combined exercise and diet interventions show potential in improving ovarian cancer patients' outcomes

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
(Logout)
Post

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback

You might also like...
Mainz Biomed to unveil breakthrough early cancer detection study results at DDW 2024